Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Price:
36.21 USD
-1.5%
Market Closed
Updated:
May 29, 2024
Rhythm Pharmaceuticals Inc
Net Issuance of Common Stock
|
Rhythm Pharmaceuticals Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
Net Issuance of Common Stock
$63.2m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rhythm Pharmaceuticals Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
63.2m
USD
63.2m
USD
Based on the financial report for Mar 31, 2024, Rhythm Pharmaceuticals Inc's Net Issuance of Common Stock amounts to 63.2m USD.
What is Rhythm Pharmaceuticals Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-17%
-17%
Over the last year, the Net Issuance of Common Stock growth was -56%. The average annual Net Issuance of Common Stock growth rates for Rhythm Pharmaceuticals Inc have been -28% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
